Mr Chav denis, Cavendish "my bet more jam tomorrow waffle and no apology for lack of communication and the big lie about sales update before September"
I guess you are sitting on a large paper loss now, you were once incredibly bullish.
"Will be along the lines of, covid sales have proved tougher than we expected but AIHL sales will come on line next year and save us. If these don't commence in quarter one, we may need a small raise to tide us over."
It's as if you have writing the financial report yourself. Based on your prediction would you dare pick a number regarding the share price before Christmas?
"The Company will provide a live presentation to accompany the results, presented by CEO, David Budd and CFO, Russ Shaw on Monday, 21 November 2022 at 12.00pm."
imagine being one of the researchers at GDR - not understanding why your overpaid bosses can't sell the outstanding products you've helped create, ot knowing whether a placement will be successful and you'll be not be made redundant before christmas each year. The boards actions ove rthe last 2 year suggest they don't respect their employees imo.
if there is another placing due to lack of significant sales then don't forget, there will be another placing approximately a year later. GDR is like a broken record - its strategy to keep the lights on is fleecing pi's with the help of ii's.
RE: NHS urged to offer patients better access to genetic testing7 Nov 2022 16:36
>At current sp and rates of interest I think we'd be lucky to have a buyer at 20p.
current price is 11p. Not even Mr Musk would buy GDR for almost twice the current market value. Besides no-one will be interested, GDR's costs are far too high.
In the long term the genomic service will replace AIHL. Does Mr Budd realise he has to sell his AIHL kit fast (assuming he's true to form and they sold nothing so far)!? Genomic medicine is the future and GDR's competitors are on the ball.
Test results should be available in anything between two and seven days, depending on the complexity of the child’s condition, though that should get faster as technology improves, Baple added.
“We know that with prompt and accurate diagnosis conditions could be cured or better managed with the right clinical care, which would be life-altering and potentially life-saving for so many seriously unwell babies and children.”
I wonder whether ii's will risk fleecing private investors again this year.